Free Trial

Fortrea (NASDAQ:FTRE) Shares Gap Down on Disappointing Earnings

Fortrea logo with Medical background
Remove Ads

Fortrea Holdings Inc. (NASDAQ:FTRE - Get Free Report) gapped down prior to trading on Monday after the company announced weaker than expected quarterly earnings. The stock had previously closed at $13.85, but opened at $9.61. Fortrea shares last traded at $11.49, with a volume of 1,761,855 shares changing hands.

The company reported $0.18 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.36 by ($0.18). Fortrea had a positive return on equity of 2.00% and a negative net margin of 10.99%. The company had revenue of $697.00 million for the quarter, compared to the consensus estimate of $703.22 million. During the same period in the prior year, the firm posted $0.19 earnings per share.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on FTRE. Evercore ISI reduced their price objective on Fortrea from $20.00 to $15.00 and set an "in-line" rating on the stock in a research report on Tuesday. TD Cowen increased their price target on shares of Fortrea from $23.00 to $25.00 and gave the company a "hold" rating in a research report on Monday, November 11th. Citigroup downgraded shares of Fortrea from a "buy" rating to a "neutral" rating and decreased their price target for the stock from $30.00 to $23.00 in a research note on Wednesday, December 11th. The Goldman Sachs Group cut their price objective on shares of Fortrea from $22.00 to $11.00 and set a "neutral" rating for the company in a research note on Tuesday. Finally, Barclays decreased their target price on shares of Fortrea from $25.00 to $12.00 and set an "equal weight" rating on the stock in a research report on Tuesday. One investment analyst has rated the stock with a sell rating and eleven have given a hold rating to the company's stock. According to data from MarketBeat.com, Fortrea has an average rating of "Hold" and an average target price of $20.30.

Remove Ads

Check Out Our Latest Stock Analysis on FTRE

Insider Buying and Selling at Fortrea

In related news, CEO Thomas Pike sold 11,268 shares of the firm's stock in a transaction dated Monday, January 13th. The stock was sold at an average price of $18.04, for a total value of $203,274.72. Following the sale, the chief executive officer now directly owns 159,868 shares of the company's stock, valued at $2,884,018.72. This trade represents a 6.58 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Over the last quarter, insiders have sold 12,386 shares of company stock worth $219,751. 0.12% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Fortrea

Several institutional investors and hedge funds have recently modified their holdings of the stock. JPMorgan Chase & Co. raised its stake in Fortrea by 21.2% in the third quarter. JPMorgan Chase & Co. now owns 364,413 shares of the company's stock worth $7,288,000 after buying an additional 63,766 shares in the last quarter. Starboard Value LP boosted its position in shares of Fortrea by 5.0% during the third quarter. Starboard Value LP now owns 8,400,000 shares of the company's stock valued at $168,000,000 after purchasing an additional 400,000 shares in the last quarter. State Street Corp boosted its position in shares of Fortrea by 7.7% during the third quarter. State Street Corp now owns 3,250,693 shares of the company's stock valued at $65,014,000 after purchasing an additional 233,577 shares in the last quarter. Mutual of America Capital Management LLC grew its stake in Fortrea by 9.0% in the third quarter. Mutual of America Capital Management LLC now owns 495,444 shares of the company's stock worth $9,909,000 after purchasing an additional 40,748 shares during the period. Finally, Diamond Hill Capital Management Inc. raised its holdings in Fortrea by 20.5% in the third quarter. Diamond Hill Capital Management Inc. now owns 1,197,696 shares of the company's stock worth $23,954,000 after purchasing an additional 204,021 shares in the last quarter.

Fortrea Price Performance

The firm has a 50-day simple moving average of $16.50 and a 200 day simple moving average of $18.95. The firm has a market cap of $958.89 million, a PE ratio of -3.13, a price-to-earnings-growth ratio of 1.78 and a beta of 1.34. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.18 and a quick ratio of 1.18.

Fortrea Company Profile

(Get Free Report)

Fortrea Holdings Inc, a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum.

Featured Stories

Should You Invest $1,000 in Fortrea Right Now?

Before you consider Fortrea, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fortrea wasn't on the list.

While Fortrea currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for March 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Will Tesla’s Robot Future Save Its Falling Stock?
NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last
Best ETFs for Spring 2025: Strong and Steady Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads